Macular Degeneration Treatment with MacuCLEAR MacuCLEAR Inc. is a specialty clinical-stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. MacuCLEAR has an active IND for MC-1101 and has completed a novel and successful Phase Ib/POC human clinical trial. Macuclear.com~Site InfoWhoisTrace RouteRBL Check